BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33278800)

  • 1. Linking neuroinflammation to motor neuron degeneration in ALS: The critical role of CXCL13/CXCR5.
    Arnoux A; Dupuis L
    EBioMedicine; 2021 Jan; 63():103149. PubMed ID: 33278800
    [No Abstract]   [Full Text] [Related]  

  • 2. CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis.
    Trolese MC; Mariani A; Terao M; de Paola M; Fabbrizio P; Sironi F; Kurosaki M; Bonanno S; Marcuzzo S; Bernasconi P; Trojsi F; Aronica E; Bendotti C; Nardo G
    EBioMedicine; 2020 Dec; 62():103097. PubMed ID: 33161233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice.
    Zhang Q; Cao DL; Zhang ZJ; Jiang BC; Gao YJ
    J Neuroinflammation; 2016 Jul; 13(1):183. PubMed ID: 27401148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the mechanisms involved in motor neuron degeneration in ALS.
    Bruijn LI; Miller TM; Cleveland DW
    Annu Rev Neurosci; 2004; 27():723-49. PubMed ID: 15217349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitigating Motor Neuronal Loss in C. elegans Model of ALS8.
    Zhang W; Colavita A; Ngsee JK
    Sci Rep; 2017 Sep; 7(1):11582. PubMed ID: 28912432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis.
    Lowry KS; Murray SS; McLean CA; Talman P; Mathers S; Lopes EC; Cheema SS
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Sep; 2(3):127-34. PubMed ID: 11771768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5.
    Jiang BC; Cao DL; Zhang X; Zhang ZJ; He LN; Li CH; Zhang WW; Wu XB; Berta T; Ji RR; Gao YJ
    J Clin Invest; 2016 Feb; 126(2):745-61. PubMed ID: 26752644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
    Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A
    Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation.
    Varghese AM; Ghosh M; Bhagat SK; Vijayalakshmi K; Preethish-Kumar V; Vengalil S; Chevula PC; Nashi S; Polavarapu K; Sharma M; Dhaliwal RS; Philip M; Nalini A; Alladi PA; Sathyaprabha TN; Raju TR
    J Neuroinflammation; 2020 Aug; 17(1):232. PubMed ID: 32762702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying motor neuron loss in ALS.
    Narasimhan K
    Nat Neurosci; 2006 Mar; 9(3):304. PubMed ID: 16498424
    [No Abstract]   [Full Text] [Related]  

  • 11. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
    Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
    Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
    Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
    Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
    J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13/CXCR5 enhances sodium channel Nav1.8 current density via p38 MAP kinase in primary sensory neurons following inflammatory pain.
    Wu XB; Cao DL; Zhang X; Jiang BC; Zhao LX; Qian B; Gao YJ
    Sci Rep; 2016 Oct; 6():34836. PubMed ID: 27708397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate-starved neurons in ALS.
    Martinez BA
    Dis Model Mech; 2012 Nov; 5(6):711-2. PubMed ID: 23115199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.
    Del Grosso F; Coco S; Scaruffi P; Stigliani S; Valdora F; Benelli R; Salvi S; Boccardo S; Truini M; Croce M; Ferrini S; Longo L; Tonini GP
    Mol Cancer Res; 2011 Jul; 9(7):815-23. PubMed ID: 21642390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excitotoxicity in ALS: Overstimulation, or overreaction?
    King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2016 Jan; 275 Pt 1():162-71. PubMed ID: 26584004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
    Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
    Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
    Chi L; Ke Y; Luo C; Gozal D; Liu R
    Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis.
    Ringer C; Weihe E; Schütz B
    Neurobiol Dis; 2012 Jan; 45(1):547-54. PubMed ID: 21964254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.